Clinical Trial Update: An Exploratory Clinical Study of Adebelimumab in Combination With Famitinib and Chemotherapy in Patients With NSCLC [Phase 2]

View source ↗

Summary

Phase 2 exploratory trial exploring Adebelimumab with Famitinib and chemotherapy for non-small cell lung cancer was withdrawn. Sponsor: Jiangsu Province Nanjing…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Adebelimumab (Adebelimumab)
• Famitinib (Famitinib)

Snippet

Sponsor: Jiangsu Province Nanjing Brain Hospital | Conditions: NSCLC | Phase 2 | Status: WITHDRAWN